Search

Your search keyword '"Mario Furlanut"' showing total 91 results

Search Constraints

Start Over You searched for: Author "Mario Furlanut" Remove constraint Author: "Mario Furlanut"
91 results on '"Mario Furlanut"'

Search Results

1. Educational and Organizational Interventions to Improve the Usefulness of Clinical Pharmacological Advice for Personalized Drug Dosing Based on Therapeutic Drug Monitoring

2. A simple method to monitor serum concentrations of fluoxetine and its major metabolite for pharmacokinetic studies

3. Pharmacokinetic Considerations for Antimicrobial Therapy in Patients Receiving Renal Replacement Therapy

4. Therapeutic Mycophenolic Acid Monitoring by Means of Limited Sampling Strategy in Orthotopic Heart Transplant Patients

5. A simple method to monitor plasma concentrations of oxcarbazepine, carbamazepine, their main metabolites and lamotrigine in epileptic patients

6. Levofloxacin Disposition in Cerebrospinal Fluid in Patients with External Ventriculostomy

7. Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients

8. Pharmacokinetic Profile of Two Different Administration Schemes of Teicoplanin

9. The teaching of pharmacology in Italian medical schools: the point of view of Italian doctors

10. Effect of the Number of Samples on Bayesian and Non-linear Least-squares Individualization: A Study of Cyclosporin Treatment of Haematological Patients with Multidrug Resistance

11. SEPARATION OFDL-DOPA BY MEANS OF MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY AFTER DERIVATIZATION WITH MARFEY'S REAGENT

12. PREDICTION OF BLOOD CYCLOSPORINE CONCENTRATIONS IN HAEMATOLOGICAL PATIENTS WITH MULTIDRUG RESISTANCE BY ONE-, TWO- AND THREE-COMPARTMENT MODELS USING BAYESIAN AND NON-LINEAR LEAST SQUARES METHODS

13. Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach

14. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients

15. Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapy

16. Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus

17. Development and Validation of a Liquid Chromatography–Tandem Mass Spectrometry Method for the Determination of Voriconazole and Posaconazole in Serum Samples

18. Plasma Levels of Levodopa and Its Main Metabolites in Parkinsonian Patients after Conventional and Controlled-Release Levodopa-Carbidopa Associations

19. Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients

20. Fluoxetine disposition in patients with chronic hepatitis C treated with interferon-α

21. Is the use of vancomycin doses of at least 1 g every 8 hours the only way to achieve optimal trough levels in critically ill trauma patients with pneumonia and normal renal function?

22. A simple and sensitive HPLC method ti monitor serum and synovial fluid concnetrations of ketorolac in reumathologic patients

23. Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis

24. Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients

25. What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice?

27. Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients

28. Contributors

29. Hydrogen bonding as a possible interaction for the chiral separation of dl-dopa and dl-3-O-methyl-dopa in a chiral teicoplanin column

30. Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin

31. Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient

32. Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients

33. Focus on antibiotics: use and misuse in the intensive care unit, and antibiotics monitoring

34. Daunorubicin and daunorubicinol tissue concentrations in gastric cancer patients after local administration of a liposomal preparation

35. Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose

36. Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis

37. Tamoxifen and its main metabolites serum and tissue concentration in breast cancer women

38. Chronopharmacokinetics of ciclosporin and tacrolimus

39. Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis

40. Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective

41. LEVODOPA AND 3-O-METHYLDOPA IN CEREBROSPINAL FLUID AFTER LEVODOPA-CARBIDOPA ASSOCIATION

42. The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin

43. Ceftazidime in Acute Myeloid Leukemia Patients with Febrile Neutropenia: Helpfulness of Continuous Intravenous Infusion in Maximizing Pharmacodynamic Exposure

44. Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery

45. Antimicrobial therapy in critically ill patients: A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability

46. Teicoplanin in patients with acute leukaemia and febrile neutropenia: A special population benefiting from higher dosages

47. Short Communication

48. MEGX disposition in critically-ill trauma patients: subsequent assessments during the first week following trauma

49. Disposition of liposomal daunorubicin during cotreatment with cytarabine in patients with leukaemia

50. Teicoplanin therapeutic drug monitoring in critically ill patients: A retrospective study emphasizing the importance of a loading dose

Catalog

Books, media, physical & digital resources